IGF1 and neoplasm: Additionally, adipose‐induced insulin resistance and insulin‐like growth factor‐1 (IGF‐1) production can lead to hyperglycemia, excess circulating steroid hormones, and elevated free fatty acid levels, all of which contribute to metabolic dysfunction and tumor progression.3, 6